Multi-View Graph Convolutional Network and Its Applications on Neuroimage Analysis for Parkinson's Disease

Parkinson's Disease (PD) is one of the most prevalent neurodegenerative diseases that affects tens of millions of Americans. PD is highly progressive and heterogeneous. Quite a few studies have been conducted in recent years on predictive or disease progression modeling of PD using clinical and biomarkers data. Neuroimaging, as another important information source for neurodegenerative disease, has also arisen considerable interests from the PD community. In this paper, we propose a deep learning method based on Graph Convolutional Networks (GCN) for fusing multiple modalities of brain images in relationship prediction which is useful for distinguishing PD cases from controls. On Parkinson's Progression Markers Initiative (PPMI) cohort, our approach achieved 0.9537±0.0587 AUC, compared with 0.6443±0.0223 AUC achieved by traditional approaches such as PCA.

[1]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[2]  M. Raichle,et al.  Tracking neuronal fiber pathways in the living human brain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[4]  Junzhou Huang,et al.  IMAGING GENOMICS. , 2018, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[5]  Brian B. Avants,et al.  Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..

[6]  Fei Wang,et al.  Measuring Patient Similarities via a Deep Architecture with Medical Concept Embedding , 2016, 2016 IEEE 16th International Conference on Data Mining (ICDM).

[7]  G. Sapiro,et al.  Reconstruction of the orientation distribution function in single‐ and multiple‐shell q‐ball imaging within constant solid angle , 2010, Magnetic resonance in medicine.

[8]  Marios Politis,et al.  Neuroimaging in Parkinson disease: from research setting to clinical practice , 2014, Nature Reviews Neurology.

[9]  Mariano Rivera,et al.  Basis Tensor Decomposition for Restoring Intra-Voxel Structure and Stochastic Walks for Inferring Brain Connectivity in DT-MRI , 2006, International Journal of Computer Vision.

[10]  Philip S. Yu,et al.  Identifying Connectivity Patterns for Brain Diseases via Multi-side-view Guided Deep Architectures , 2016, SDM.

[11]  L. Minati,et al.  Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging. , 2007, AJNR. American journal of neuroradiology.

[12]  Cassandra D. Leonardo,et al.  Comparison of nine tractography algorithms for detecting abnormal structural brain networks in Alzheimer’s disease , 2015, Front. Aging Neurosci..

[13]  A. Alexander,et al.  White matter tractography using diffusion tensor deflection , 2003, Human brain mapping.

[14]  A. Stefani,et al.  Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. , 2010, Brain : a journal of neurology.

[15]  Xavier Bresson,et al.  Convolutional Neural Networks on Graphs with Fast Localized Spectral Filtering , 2016, NIPS.

[16]  P. Basser,et al.  In vivo fiber tractography using DT‐MRI data , 2000, Magnetic resonance in medicine.

[17]  Ming Tang,et al.  Predictive Big Data Analytics: A Study of Parkinson’s Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations , 2016, PloS one.

[18]  Pascal Frossard,et al.  The emerging field of signal processing on graphs: Extending high-dimensional data analysis to networks and other irregular domains , 2012, IEEE Signal Processing Magazine.

[19]  Essa Yacoub,et al.  A Hough transform global probabilistic approach to multiple-subject diffusion MRI tractography , 2011, Medical Image Anal..

[20]  Ming Shao,et al.  Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson's disease and multiple system atrophy. , 2014, European journal of radiology.

[21]  Lippincott Williams Wilkins,et al.  High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease , 2009, Neurology.

[22]  Jimmy Ba,et al.  Adam: A Method for Stochastic Optimization , 2014, ICLR.

[23]  P. V. van Zijl,et al.  Three‐dimensional tracking of axonal projections in the brain by magnetic resonance imaging , 1999, Annals of neurology.

[24]  Fei Wang,et al.  Unsupervised Network Discovery for Brain Imaging Data , 2017, KDD.

[25]  Yoshiharu Tamakawa,et al.  The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. , 2002, AJNR. American journal of neuroradiology.

[26]  Gregory R. Koch,et al.  Siamese Neural Networks for One-Shot Image Recognition , 2015 .

[27]  Christos Davatzikos,et al.  Imaging genomics in cancer research: limitations and promises. , 2016, The British journal of radiology.

[28]  Ulrike von Luxburg,et al.  A tutorial on spectral clustering , 2007, Stat. Comput..

[29]  Lucas C. Parra,et al.  Nonnegative matrix factorization for rapid recovery of constituent spectra in magnetic resonance chemical shift imaging of the brain , 2004, IEEE Transactions on Medical Imaging.

[30]  Xiangnan Kong,et al.  Unified and Contrasting Graphical Lasso for Brain Network Discovery , 2017, SDM.

[31]  Kaustubh Supekar,et al.  Sparse logistic regression for whole-brain classification of fMRI data , 2010, NeuroImage.

[32]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[33]  Tom M. Mitchell,et al.  Machine learning classifiers and fMRI: A tutorial overview , 2009, NeuroImage.

[34]  Dinggang Shen,et al.  Machine Learning in Medical Imaging , 2012, Lecture Notes in Computer Science.

[35]  Max Welling,et al.  Semi-Supervised Classification with Graph Convolutional Networks , 2016, ICLR.

[36]  Jiaquan Xu,et al.  Deaths: Final Data for 2014. , 2016, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[37]  Klaus-Robert Müller,et al.  Introduction to machine learning for brain imaging , 2011, NeuroImage.

[38]  Antonio P. Strafella,et al.  Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts , 2017, Translational Neurodegeneration.

[39]  Margaret Sutherland,et al.  Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study , 2015, The Lancet Neurology.

[40]  Ben Glocker,et al.  Distance Metric Learning Using Graph Convolutional Networks: Application to Functional Brain Networks , 2017, MICCAI.

[41]  Marie Chupin,et al.  Spatial and anatomical regularization of SVM for brain image analysis , 2010, NIPS.

[42]  J. Schott,et al.  Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study , 2017, The Lancet Neurology.

[43]  Dean F. Wong,et al.  CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson’s Disease—A Preliminary Report , 2016, PloS one.

[44]  Subhransu Maji,et al.  Multi-view Convolutional Neural Networks for 3D Shape Recognition , 2015, 2015 IEEE International Conference on Computer Vision (ICCV).

[45]  Steven L. Bressler,et al.  Foundational perspectives on causality in large-scale brain networks. , 2015, Physics of life reviews.

[46]  Fei Wang,et al.  Drug Similarity Integration Through Attentive Multi-view Graph Auto-Encoders , 2018, IJCAI.